Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by the B.1.351 variant in the Eastern Cape, South Africa
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology Plus
- Vol. 1 (1-2) , 100013
Abstract
No abstract availableKeywords
All Related Versions
This publication has 6 references indexed in Scilit:
- Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?Journal of Clinical Medicine, 2021
- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)Nature Communications, 2021
- Non-resonant power-efficient directional Nd:YAG ceramic laser using a scattering cavityNature Communications, 2021
- Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptomsJournal of Clinical Virology, 2020
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infectionCochrane Database of Systematic Reviews, 2020
- Biochemical characterization of SARS-CoV-2 nucleocapsid proteinBiochemical and Biophysical Research Communications, 2020